This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: FDX, FITB, JBLU, AKS, ABX

United Parcel Service (UPS) downgraded at Jefferies to Hold from Buy, Jefferies said. $81 price target. Short-cycle indicators recently turned negative.

US Bancorp (USB) downgraded at Citigroup from Buy to Neutral, Citigroup said. $30 price target. Valuation call.

VMWare (VMW) rated new Overweight at Evercore. $105 price target. Recent pullback creates attractive risk/reward for server virtualization leader.

Westlake Chemical (WLK) upgraded at Goldman to Buy, Goldman Sachs said. $67 price target. Company should benefit from declining ethane prices.

Williams-Sonoma (WSM) downgraded at Oppenheimer to Perform from Outperform, Jefferies said. $37 price target. Margin pressures an issue.


Apple (AAPL) target raised at Jefferies to $550, Jefferies said. Expecting strength driven by iPhone 4S. Buy rating. (AMZN) estimates, target lowered at Benchmark. Shares of AMZN now seen reaching $210. Estimates also cut, given lower realized margins. Buy rating.

Anadarko (APC) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Adjustments based on changes in NYMEX futures oil and gas prices. Outperform rating.

Beam (BEAM) cut from Conviction Buy List at Goldman. MNST offers better value at current levels. $55 price target.

Carnival (CCL) estimates, target cut at Goldman. Shares of CCL now seen reaching $39. Estimates also reduced, given the grounding of the Concordia vessel. Buy rating.

Carnival estimates lowered at UBS through 2012, UBS said. Impact from Concordia issue. Maintain Buy rating and $38 price target.

Celgene (CELG) estimates target increased at JMP through 2012, JMP Securities said. Company has several potential growth drivers. Outperform rating and new $88 price target.

Discover Financial (DFS) numbers upped at Goldman through 2013, Goldman Sachs said. Company is seeing lower expenses and should see better credit results. Neutral rating and new $30 price target.

Dow Chemical (DOW) numbers raised at Goldman. Shares of DOW now seen reaching $38, according to Goldman Sachs. Estimates also increased, given lower expected ethane costs. Neutral rating.

Home Depot (HD) numbers increased at Goldman. HD estimates were raised through 2012, Goldman Sachs said. Company is buying back more stock. Neutral rating and new $45 price target.

Hospira (HSP) added to US 1 List at BofA/Merrill. HSP was placed on the US 1 list, Bank of America/Merrill Lynch said. $38 price target. Stock is attractively valued, down some 45% over the past year.

JP Morgan Chase (JPM) estimates lowered at UBS through 2013, UBS said. Universal bank consensus estimates are too high. Maintain Buy rating and $44 price target.

JP Morgan Chase numbers raised at Citigroup. Shares of JPM now seen reaching $42. Estimates also increased on slightly larger balance sheet growth. Buy rating.

JP Morgan numbers reduced at Goldman. Shares of JPM now seen reaching $41, according to Goldman Sachs. Estimates also cut, given lower capital markets activity. Buy rating.

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ICE $236.28 0.00%
AKS $2.80 0.00%
ABX $7.30 0.00%
FITB $18.95 0.00%
FDX $151.51 0.00%


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs